ORKA-002-211 A Phase I Study to Evaluate ORKA-002 in Healthy Volunteers Following A Single Dose

Clinical trial NCT06944379 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06944379
Sponsor: Oruka Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2025-05-19
Primary completion: 2027-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.